In contrast, after 24 h of treatment with UBX‐390, the levels of proteins associated with the AR and prostate cancer signaling pathways were downregulated compared to those observed after treatment with dimethyl sulfoxide (DMSO) (Figure 2B). Here, AR is linked to prostate cancer.